Impressive
impact factors show that BioMed Central's Open Access journals
are high quality and widely read and cited. Journals published
by BioMed Central have again received impact factors that
compare well with equivalent subscription titles, with five
titles in the top five of their specialty. The high impact
factors for these journals affirm that they are respected by
researchers, and are fast becoming the place for authors to
submit important research
findings.
Five journals published by BioMed Central
received their first impact factors this year. BMC
Bioinformatics, with an impact factor of 5.42, has reinforced
its reputation as one of the top journals in its field.
Launched in 2000, it is the second highest ranked
bioinformatics journal, and already has an impact factor
comparable to that of Bioinformatics (5.74), the most
established journal in the field, which has been publishing
for more than two decades and is supported by a major society.
|
|
BMC Genomics enters the Journal
Citation Report with a respectable 3.25. This puts it in the
top third of the genetics titles, and the top 20 percent of
biotechnology journals. BMC Molecular Biology has an impact
factor of 3.12, and BMC Musculoskeletal Disorders an impact
factor of 1.00, putting it in the top half of the orthopaedics
listing. BMC Genetics has an impact factor of 0.92. The impact
factors, which are calculated by ISI, look at citations in
2004 of articles published in the journals in the period
2002-2003.
According to Dr Matthew Cockerill,
Director of Operations at BioMed Central, "These latest impact
factors show that BioMed Central's Open Access journals have
joined the mainstream of science publishing, and can compete
with traditional journals on their own terms. The impact
factors also demonstrate one of the key benefits that Open
Access offers authors: high visibility and, as a result, a
high rate of citation."
|
